Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Astellas Pharma Inc. : quaterly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
01/28/2020 | 09:15am EDT

The company will report its earnings for Q3 2019 on 01/31/2020. Generally, the company reports earnings better than estimates. In recent months, the 13 analysts from Standard & Poor's consensus have not revised their EPS estimates.


© MarketScreener.com 2020
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ASTELLAS PHARMA INC.
05/28ASTELLAS PHARMA INC. : - FDA Approves VESIcare LS Oral Suspension for Pediatric ..
AQ
05/21ASTELLAS PHARMA INC. : - Notice Regarding Continuation of the Performance-linked..
AQ
05/21ASTELLAS PHARMA : European Medicines Agency Accepts Astellas Marketing Authoriza..
AQ
05/14ASTELLAS PHARMA : Immunomic Therapeutics, Inc. - Maryland's Immunomic Therapeuti..
AQ
05/11ASTELLAS PHARMA INC. : annual earnings release
04/29ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
04/27ASTELLAS PHARMA : and Harvard Establish Strategic Research Alliance
PU
04/27ASTELLAS PHARMA INC. : - Change of Directors and Organizational Change
AQ
04/21ASTELLAS PHARMA : Announces Acquisition of Nanna
AQ
04/10ASTELLAS PHARMA : Announces Acceptance of XOSPATA for Regulatory Review in China..
AQ
More news
Financials
Sales 2020 1 275 B 11 714 M 11 714 M
Net income 2020 204 B 1 870 M 1 870 M
Net cash 2020 458 B 4 208 M 4 208 M
P/E ratio 2020 17,1x
Yield 2020 2,12%
Capitalization 3 591 B 33 082 M 33 001 M
EV / Sales 2019
EV / Sales 2020 2,46x
Nbr of Employees 16 243
Free-Float 98,1%
Chart ASTELLAS PHARMA INC.
Duration : Period :
Astellas Pharma Inc. Technical Analysis Chart | 4503 | JP3942400007 | MarketScreener
Technical analysis trends ASTELLAS PHARMA INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 2 133,33 JPY
Last Close Price 1 932,50 JPY
Spread / Highest target 44,9%
Spread / Average Target 10,4%
Spread / Lowest Target -22,4%
EPS Revisions
Managers
NameTitle
Kenji Yasukawa President, CEO & Representative Director
Yoshihiko Hatanaka Chairman
Naoki Okamura Representative Director & Vice President
Tomokazu Fujisawa Director
Hiroko Sakai Director
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC.3.34%34 009
JOHNSON & JOHNSON1.63%387 786
ROCHE HOLDING AG5.96%295 188
MERCK & CO., INC.-11.12%200 817
PFIZER, INC.-7.71%196 974
NOVARTIS AG-9.65%190 248